The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being ...

Improvements in health care in Eswatini have relied for years on Pepper and the generosity of the American people. During the ...

Staffers at the remnants of the United States Agency for International Development (USAID), the foreign aid agency dismantled ...

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

Drugmaker Gilead Sciences is not only providing the shot in the US, but is also working with governments and health groups in the UK and low-income countries to make these products more available.

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting ...